Abstract
Antioxidants & Redox SignalingVol. 7, No. 9-10 Forum EditorialCNS Mitochondria in Neurodegenerative DisordersJanet M. DubinskyJanet M. DubinskySearch for more papers by this authorPublished Online:22 Aug 2005https://doi.org/10.1089/ars.2005.7.1089AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited ByFDA-approved 5-HT1F receptor agonist lasmiditan induces mitochondrial biogenesis and enhances locomotor and blood-spinal cord barrier recovery after spinal cord injuryExperimental Neurology, Vol. 341Combination therapy with astaxanthin and epidermal neural crest stem cells improves motor impairments and activates mitochondrial biogenesis in a rat model of spinal cord injuryMitochondrion, Vol. 52Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseasesExperimental Neurology5-HT1F Receptor Agonist Induces Mitochondrial Biogenesis and Promotes Recovery from Spinal Cord Injury27 November 2019 | Journal of Pharmacology and Experimental TherapeuticsPharmacological Stimulation of Mitochondrial Biogenesis Using the Food and Drug Administration-Approved β2-Adrenoreceptor Agonist Formoterol for the Treatment of Spinal Cord Injury Natalie E. Scholpa, Hannah Williams, Wenxue Wang, Daniel Corum, Aarti Narang, Stephen Tomlinson, Patrick G. Sullivan, Alexander G. Rabchevsky, and Rick G. Schnellmann1 March 2019 | Journal of Neurotrauma, Vol. 36, No. 6Molecular Regulation Mechanisms and Interactions Between Reactive Oxygen Species and Mitophagy Pan Fan, Xing-Hui Xie, Chang-Hong Chen, Xin Peng, Po Zhang, Cheng Yang, and Yun-Tao Wang7 January 2019 | DNA and Cell Biology, Vol. 38, No. 15-HT 1F receptor-mediated mitochondrial biogenesis for the treatment of Parkinson's disease22 December 2017 | British Journal of Pharmacology, Vol. 175, No. 2Mitochondrial-Based Therapeutics for the Treatment of Spinal Cord Injury: Mitochondrial Biogenesis as a Potential Pharmacological Target21 September 2017 | Journal of Pharmacology and Experimental Therapeutics, Vol. 363, No. 3Hypoxia Activation of Mitophagy and Its Role in Disease Pathogenesis Hao Wu and Quan Chen7 April 2015 | Antioxidants & Redox Signaling, Vol. 22, No. 126.4 Mitochondrial Permeability Transition in the CNS—Composition, Regulation, and Pathophysiological Relevance1 January 2007 Volume 7Issue 9-10Sep 2005 InformationCopyright 2005, Mary Ann Liebert, Inc.To cite this article:Janet M. Dubinsky.CNS Mitochondria in Neurodegenerative Disorders.Antioxidants & Redox Signaling.Sep 2005.1089-1091.http://doi.org/10.1089/ars.2005.7.1089Published in Volume: 7 Issue 9-10: August 22, 2005PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
